Security key
03237H101
Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (AMLX)
CUSIP: 03237H101
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 110,465,093
- Total 13F shares
- 109,720,694
- Share change
- +28,023,346
- Total reported value
- $1,491,122,082
- Put/Call ratio
- 37%
- Price per share
- $13.59
- Number of holders
- 168
- Value change
- +$396,029,872
- Number of buys
- 99
- Number of sells
- 67
Report period
Q3 2025
Institutions
168
Top holders
10
AMLX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Previous quarter: Q2 2025
Amylyx Pharmaceuticals, Inc. SEC filings
Amylyx Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03237H101
Recent filing periods:
Ownership snapshot
Top shareholders of AMLX - Amylyx Pharmaceuticals, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Lead holder
Point72 Asset Management,...
13D/G signal
Point72 Asset Management,...
Evidence rows
50
Latest as of
30 Sep 2025
13D/G
13F
Lead comparable stake: 2.6%
13D/G row: Point72 Asset Management, L.P.
Showing first 8 of 50 holder rows.
Open remaining rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Point72 Asset Management, L.P. |
13D/G
13F
Company
|
2.6%
|
$38,074,233
2,801,636 shares
|
-$26,039,432 | 30 Sep 2025 |
| Panacea Innovation Ltd |
13D/G
Panacea Venture Healthcare Fund II, L.P.
|
2.6%
|
$11,792,000
2,200,000 shares
|
$0 | 31 Dec 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
8%
|
$56,408,000
8,800,000 shares
|
— | 30 Jun 2025 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
7.2%
|
$50,654,160
7,902,365 shares
|
— | 30 Jun 2025 |
| TCG Crossover Management, LLC |
13F
Company
|
5.4%
|
$38,099,835
5,943,812 shares
|
— | 30 Jun 2025 |
| BlackRock, Inc. |
13F
Company
|
5%
|
$35,320,311
5,510,189 shares
|
— | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
Company
|
4.1%
|
$28,832,360
4,498,028 shares
|
— | 30 Jun 2025 |
| Saturn V Capital Management LP |
13F
Company
|
3%
|
$20,900,254
3,260,570 shares
|
— | 30 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
168
Shares
109,720,694
Rows loaded
169
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
131
Q3 2025 holders
168
Holder diff
37
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend